Quadratus Lumborum versus Transversus Abdominis Plane Block with Oxycodone or Sufentanil for Recovery Quality After Laparoscopic Gastrointestinal Cancer Surgery: A Factorial Randomized Trial.

Drug Des Devel TherOct 24, 2026 (epub)
Case ReportAnesthesiologyOncology (Medical)Open access

Guo-Wang Yang, Xiao-Yang Song, Yu-Fan Yang et al.

✦ AI-curated · Sources linked

Condensed from the publisher's abstract. An xxcode editorial summary of this publication has not been generated yet.

From the abstract

Quadratus lumborum block (QLB) theoretically provides broader visceral analgesia than transversus abdominis plane block (TAPB), while oxycodone, a dual μ- and κ-opioid receptor agonist, may offer superior visceral pain control compared with sufentanil.

Reported results

For 24-h recovery quality, no significant interaction was found between block and opioid ( P = 0.283); QLB vs TAPB (mean [SD] 102.1 [7.9] vs 102.6 [7.6]; mean difference -0.5, 95% CI -3.3 to 2.4; P = 0.740) and oxycodone vs sufentanil (103.7 [6.9] vs 100.9 [8.3]; mean difference 2.8, 95% CI 0.1 to 5.6; P = 0.045) did not reach the Bonferroni-corrected threshold ( P < 0.025) or the 6-point difference.

Authors' conclusions

Within comprehensive multimodal analgesia, neither QLB nor oxycodone demonstrated superior recovery compared with TAPB or sufentanil. Exploratory findings of lower postoperative pain and less rescue analgesia with oxycodone should be considered hypothesis-generating.

Source

Published in Drug Des Devel Ther. The text above is extracted from the publisher's own abstract and has not been edited by xxcode. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Anesthesiology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.